Chronic graft–versus–host disease (cGvHD) is the object of intense clinical research.
Mesenchymal stromal cells (MSC) are known to have immunomodulatory effects. Using
MSC from adipose tissue (AT–MSC) entails advantages, such as accessibility and procedural
ease for obtaining large numbers of MSC, compared with bone marrow.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to CytotherapyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
